DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,036 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $1,666,000 | -9.8% | 19,546 | -9.4% | 0.11% | -1.8% |
Q2 2015 | $1,847,000 | +7.3% | 21,575 | +6.4% | 0.11% | +6.9% |
Q1 2015 | $1,722,000 | +6.0% | 20,285 | +7.1% | 0.10% | -1.9% |
Q4 2014 | $1,624,000 | +10.2% | 18,948 | -2.3% | 0.10% | -1.0% |
Q3 2014 | $1,474,000 | +1.8% | 19,399 | +5.4% | 0.10% | +1.0% |
Q2 2014 | $1,448,000 | +6.2% | 18,398 | +1.2% | 0.10% | -1.9% |
Q1 2014 | $1,364,000 | +2.9% | 18,181 | +5.9% | 0.11% | -1.9% |
Q4 2013 | $1,326,000 | +15.0% | 17,174 | +3.2% | 0.11% | -2.7% |
Q3 2013 | $1,153,000 | +4.2% | 16,636 | -4.8% | 0.11% | -3.5% |
Q2 2013 | $1,106,000 | +4.3% | 17,475 | +2.4% | 0.12% | 0.0% |
Q1 2013 | $1,060,000 | +45.6% | 17,059 | +17.0% | 0.12% | +18.6% |
Q2 2012 | $728,000 | -10.0% | 14,579 | -0.9% | 0.10% | -1.0% |
Q1 2012 | $809,000 | +8.4% | 14,708 | -6.3% | 0.10% | -2.0% |
Q4 2011 | $746,000 | +16.7% | 15,702 | +7.0% | 0.10% | +6.4% |
Q3 2011 | $639,000 | – | 14,681 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
MIROVA | 128,368 | $16,947,000 | 9.18% |
Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |